We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
BRIMADEX/ PHARMACOR SUGAMMADEX (Pharmacor Pty Ltd)
Product name
BRIMADEX/ PHARMACOR SUGAMMADEX
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
103 (255 working days)
Active ingredients
sugammadex sodium
Registration type
New generic medicine
Indication
Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.